Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9QEA

CRYSTAL STRUCTURE OF LYSYL-TRNA SYNTHETASE FROM Mycobacterium tuberculosis COMPLEXED WITH L-LYSINE AND INHIBITOR DDD01839469

This is a non-PDB format compatible entry.
Summary for 9QEA
Entry DOI10.2210/pdb9qea/pdb
Related9qbr 9qc3 9qc4 9qdj
DescriptorLysine--tRNA ligase 1, LYSINE, 2-azanyl-6-cyclohexyl-4-ethoxy-7~{H}-pyrrolo[3,4-d]pyrimidin-5-one, ... (4 entities in total)
Functional Keywordsligase, inhibitor
Biological sourceMycobacterium tuberculosis
Total number of polymer chains1
Total formula weight58613.22
Authors
Dawson, A.,Cleghorn, L.A.T.,Davis, S.H. (deposition date: 2025-03-07, release date: 2025-08-13, Last modification date: 2025-08-27)
Primary citationDavis, S.H.,Mathieson, M.,Buchanan, K.I.,Dawson, A.,Smith, A.,Cocco, M.,Tamaki, F.K.,Post, J.M.,Baragana, B.,Jansen, C.,Kiczun, M.,Zuccotto, F.,Wood, G.,Scullion, P.,Ray, P.C.,Epemolu, O.,Lopez-Roman, E.M.,Lopez, L.G.,Engelhart, C.A.,Kim, J.,Pino, P.A.,Schnappinger, D.,Read, K.D.,Encinas, L.,Bates, R.H.,Wyatt, P.G.,Green, S.R.,Cleghorn, L.A.T.
Design and Development of Lysyl tRNA Synthetase Inhibitors, for the Treatment of Tuberculosis.
J.Med.Chem., 68:16459-16482, 2025
Cited by
PubMed Abstract: There is currently a public health crisis due to the rise of multidrug-resistant tuberculosis cases, as well as the rise in the number of deaths from tuberculosis. To achieve the United Nations Sustainable Development Goal of ending the tuberculosis epidemic by 2030, new treatments are urgently required. We previously reported the discovery of , a preclinical candidate that acted through inhibition of the lysyl tRNA synthetase (LysRS). In this report, the full medicinal chemistry program is reviewed from the original hit through to the optimized lead. The work was guided by the first crystal structures of LysRS. The physicochemical and pharmacokinetic properties were optimized to afford compounds suitable for evaluation in mouse efficacy models of tuberculosis and with the potential for clinical development.
PubMed: 40749104
DOI: 10.1021/acs.jmedchem.5c01331
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

242842

数据于2025-10-08公开中

PDB statisticsPDBj update infoContact PDBjnumon